Ignite Creation Date:
2025-12-24 @ 3:14 PM
Ignite Modification Date:
2026-02-25 @ 4:57 PM
Study NCT ID:
NCT05873192
Status:
RECRUITING
Last Update Posted:
2025-12-23
First Post:
2023-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2022-0339
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None